WO2001053474A3 - Flavobacterium heparinum expression system - Google Patents

Flavobacterium heparinum expression system Download PDF

Info

Publication number
WO2001053474A3
WO2001053474A3 PCT/IB2001/000143 IB0100143W WO0153474A3 WO 2001053474 A3 WO2001053474 A3 WO 2001053474A3 IB 0100143 W IB0100143 W IB 0100143W WO 0153474 A3 WO0153474 A3 WO 0153474A3
Authority
WO
WIPO (PCT)
Prior art keywords
expression system
flavobacterium heparinum
heparinum
flavobacterium
expression
Prior art date
Application number
PCT/IB2001/000143
Other languages
French (fr)
Other versions
WO2001053474A8 (en
WO2001053474A2 (en
Inventor
Hongsheng Su
Shao Zhongqi
Ana Lydia Tkalec
Francoise Blain
Joseph Zimmerman
Original Assignee
Ibex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ibex Pharmaceuticals Inc filed Critical Ibex Pharmaceuticals Inc
Priority to DE60127381T priority Critical patent/DE60127381D1/en
Priority to CA002397562A priority patent/CA2397562A1/en
Priority to EP01942668A priority patent/EP1252291B1/en
Priority to JP2001553935A priority patent/JP2003520598A/en
Priority to AU57908/01A priority patent/AU5790801A/en
Publication of WO2001053474A2 publication Critical patent/WO2001053474A2/en
Publication of WO2001053474A8 publication Critical patent/WO2001053474A8/en
Publication of WO2001053474A3 publication Critical patent/WO2001053474A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)

Abstract

This invention is directed to Flavobacterium heparinum foruse as a host cell organism for the expression of homologous and heterologous genes.
PCT/IB2001/000143 2000-01-21 2001-01-16 Flavobacterium heparinum expression system WO2001053474A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE60127381T DE60127381D1 (en) 2000-01-21 2001-01-16 FLAVOBAKTERIUM HEPARINUM EXPRESSION SYSTEM
CA002397562A CA2397562A1 (en) 2000-01-21 2001-01-16 Flavobacterium heparinum expression system
EP01942668A EP1252291B1 (en) 2000-01-21 2001-01-16 Flavobacterium heparinum expression system
JP2001553935A JP2003520598A (en) 2000-01-21 2001-01-16 Flavobacterium heparinum expression system
AU57908/01A AU5790801A (en) 2000-01-21 2001-01-16 Flavobacterium heparinum expression system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17756800P 2000-01-21 2000-01-21
US60/177,568 2000-01-21

Publications (3)

Publication Number Publication Date
WO2001053474A2 WO2001053474A2 (en) 2001-07-26
WO2001053474A8 WO2001053474A8 (en) 2001-08-30
WO2001053474A3 true WO2001053474A3 (en) 2002-01-17

Family

ID=22649110

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2001/000143 WO2001053474A2 (en) 2000-01-21 2001-01-16 Flavobacterium heparinum expression system

Country Status (8)

Country Link
US (2) US6841375B2 (en)
EP (1) EP1252291B1 (en)
JP (1) JP2003520598A (en)
AT (1) ATE357506T1 (en)
AU (1) AU5790801A (en)
CA (1) CA2397562A1 (en)
DE (1) DE60127381D1 (en)
WO (1) WO2001053474A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6131811A (en) 1998-05-29 2000-10-17 E-Micro Corporation Wallet consolidator
WO2001053474A2 (en) * 2000-01-21 2001-07-26 Ibex Pharmaceuticals, Inc. Flavobacterium heparinum expression system
MXPA04001334A (en) * 2001-08-13 2004-05-05 Univ Florida Materials and methods to promote repair of nerve tissue.
DE60334220D1 (en) 2002-06-03 2010-10-28 Massachusetts Inst Technology Rationally Constructed Lyases Derived from Chondroitinase B.
JP2006519977A (en) 2002-11-11 2006-08-31 アフィメトリックス インコーポレイテッド Method for identifying DNA copy number changes
US7767420B2 (en) * 2005-11-03 2010-08-03 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
US7691613B2 (en) 2006-11-03 2010-04-06 Momenta Pharmaceuticals, Inc. Glycosaminoglycan lyase IV and uses thereof
US7691612B2 (en) 2005-11-03 2010-04-06 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
US8200440B2 (en) 2007-05-18 2012-06-12 Affymetrix, Inc. System, method, and computer software product for genotype determination using probe array data

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695968A (en) * 1990-12-07 1997-12-09 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Process for production of D-α-amino acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681733A (en) * 1994-06-10 1997-10-28 Ibex Technologies Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinum
US6093563A (en) * 1994-07-08 2000-07-25 Ibex Technologies R And D, Inc. Chondroitin lyase enzymes
WO2001053474A2 (en) * 2000-01-21 2001-07-26 Ibex Pharmaceuticals, Inc. Flavobacterium heparinum expression system

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695968A (en) * 1990-12-07 1997-12-09 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Process for production of D-α-amino acids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RUDY ANTOINE ET AL.: "Isolation and molecular characterization of a novel broad-host-range plasmid from Bordetella bronchiseptica with sequence similarities to plasmids from Gram-positive microorganisms", MOLECULAR MICROBIOLOGY, vol. 6, no. 13, 1992, pages 1785 - 1799, XP001015869 *

Also Published As

Publication number Publication date
AU5790801A (en) 2001-07-31
EP1252291A2 (en) 2002-10-30
JP2003520598A (en) 2003-07-08
WO2001053474A8 (en) 2001-08-30
ATE357506T1 (en) 2007-04-15
EP1252291B1 (en) 2007-03-21
WO2001053474A2 (en) 2001-07-26
US20050153398A1 (en) 2005-07-14
US20010034043A1 (en) 2001-10-25
US6841375B2 (en) 2005-01-11
CA2397562A1 (en) 2001-07-26
DE60127381D1 (en) 2007-05-03

Similar Documents

Publication Publication Date Title
WO2001042444A3 (en) Methods for expression of genes in primates
AU6537500A (en) Phytase enzymes, nucleic acids encoding phytase enzymes and vectors and host cells incorporating same
AU5347999A (en) Dna shuffling of monooxygenase genes for production of industrial chemicals
AU2096097A (en) Nucleic acid molecules coding for debranching enzymes from maize
AU2002242633A1 (en) Fermentation process including the use of enzymes
AU2002253836A1 (en) Aptamer-mediated regulation of gene expression
WO2001053474A8 (en) Flavobacterium heparinum expression system
AU6469699A (en) Method of regulating gene expression
AU2003275416A1 (en) Compatible host/vector systems for expression of dna
AU2003298492A1 (en) Enzymatic method for the isolation of dna from plant tissue
AU2002245166A1 (en) Regulators of fungal gene expression
AU2002340898A1 (en) Design of artificial genes for use as controls in gene expression analysis systems
AU4315000A (en) Novel plasmid vector
WO1998046768A3 (en) Phenolic acid esterase and use thereof
AU2002325305A1 (en) Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression
AU3628699A (en) Transcription factors regulating the expression of ethylene-inducible genes
AU2001292310A1 (en) Method of regulating the activity of expression product of gene transferred intoliving body
AU2001216500A1 (en) DNA sequence regulating plant fruit-specific expression
AU2003282564A1 (en) Gene profiling of single or multiple cells
MX9702141A (en) Procedure to produce as well as to use acarviosyl-transferase in transformation of acarbose in acarbose homologues, for acarbose homologues production.
WO2002012480A3 (en) Yeast alpha-amylase promoter and uses thereof
AU2001284680A1 (en) Haplotypes of the alas2 gene
AU2001294513A1 (en) Haplotypes of the ntf3 gene
AU2002336237A1 (en) Method for homologous recombination using the genes bet and exo, but not gam, of the lambda recombination system
AU2001255402A1 (en) Haplotypes of the npr1 gene

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AT AU CA CZ DE DK EE FI JP KR NO SK

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

AK Designated states

Kind code of ref document: C1

Designated state(s): AU CA JP NO

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 30/2001 UNDER (81) REPLACE THE EXISTING TEXT BY "AU, CA, JP, NO"

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP NO

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2397562

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 57908/01

Country of ref document: AU

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 553935

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001942668

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001942668

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2001942668

Country of ref document: EP